SILVER SPRING, Md., Aug. 4, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but…
Month: August 2023
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Lumen Technologies, Inc. (“Lumen” or the “Company”) (NYSE: LUMN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — The primary battery market size is estimated to grow by USD 6.22 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 6.36%. The growth momentum will progress during the forecast period. The primary battery…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Toast, Inc. (“Toast” or the “Company”) (NYSE: TOST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation…
DUBLIN, Aug. 4, 2023 /PRNewswire/ — The “Bio-based Adhesives: Technology and IP Analysis” report has been added to ResearchAndMarkets.com’s offering. This comprehensive study delves into the realm of innovation within adhesives, particularly those sourced sustainably. Focusing on…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Kodiak Sciences Inc. (“Kodiak” or the “Company”) (NASDAQ: KOD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
MENLO PARK, Calif., Aug. 4, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that PacBio’s Compensation Committee of the Board of Directors granted non-qualified stock options covering an aggregate of…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of John Wiley & Sons, Inc. (“Wiley” or the “Company”) (NYSE: WLY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Aug. 4, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of 22nd Century Group, Inc. (“22nd Century” or the “Company”) (NASDAQ: XXII). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
DUBLIN, Aug. 4, 2023 /PRNewswire/ — The “Europe Pet Supplements Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The Europe pet supplements market is witnessing substantial growth, with a value of $680.00 million in 2022 and expected to…